My Account Log in

3 options

Making better drugs for children with cancer / Peter C. Adamson, Susan L. Weiner, Joseph V. Simone, and Hellen Gelband, editors.

EBSCOhost Academic eBook Collection (North America) Available online

View online

Ebook Central Academic Complete Available online

View online

National Academies Press Available online

View online
Format:
Book
Contributor:
Adamson, Peter C.
Weiner, Susan L.
Simone, Joseph V.
Gelband, Hellen.
National Cancer Policy Board (U.S.). Committee on Shortening the Time Line for New Cancer Treatments.
Institute of Medicine (U.S.)
National Research Council (U.S.)
National Academy of Sciences (U.S.)
Language:
English
Subjects (All):
Antineoplastic agents.
Oncology.
Physical Description:
xiv, 42 p.
Edition:
1st ed.
Place of Publication:
Washington, D.C. : National Academy of Sciences, 2005.
Language Note:
English
Summary:
The successes that have been achieved in treating childhood cancers stand as beacons against the less dramatic improvements for adults with cancer. Progress began to accelerate in the 1960s and 1970s, as treatment regimens were built up, primarily by building combinations of chemotherapeutic drugs. However the near absence of research in pediatric cancer drug discovery threatens to halt the progress in childhood cancer treatment achieved during the past four decades. Making Better Drugs for Children with Cancer identifies the major issues to be addressed in developing new agents for childhood cancers, the gaps in research and development, and the steps that have been suggested to move the process forward. This report also makes a new proposal to capitalize on today's science to bring new treatments to children's cancers.
Contents:
Childhood cancers: Background
Agents in use and in testing for children with cancer
The existing capacity for developing new agents specifically for childhood cancers
Putting the pieces together
Delays in testing approved agents in children
The need to prioritize agents for testing in children with cancer
Testing and labeling of drugs for pediatric use.
Notes:
Bibliographic Level Mode of Issuance: Monograph
Includes bibliographical references.
ISBN:
9786612083327
9780309181860
0309181860
9781282083325
1282083325
9780309549257
0309549256
OCLC:
923274427

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account